Delivery Order SPE2DB20D3103-SPE2DB25FP8S0
- Not listed
- This federal contract award, valued at $2,141.10, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ALBUTEIN 5% VIAL 250ML, a medical product, and is a firm fixed-price delivery order with a completion date of December 9, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,154.16, is for the delivery of ALBUTEIN 5% VIAL 500ML medical supplies. The contract type is a Delivery Order with a Firm Fixed Price pricing structure and an ultimate completion date of March 29, 2024. This contract award is not designated as a set-aside. AmerisourceBergen holds a significant...
- The Defense Logistics Agency awarded a $1,368.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp for pharmaceutical supplies, specifically ALBUKED-25 VIAL 100ML, with performance in Conshohocken, Pennsylvania and an ultimate completion date of September 24, 2025. This non-set-aside competitive award was issued on September 3, 2025, and represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. AmerisourceBergen...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,070.55 firm fixed price delivery order is for the supply of ALBUTEIN 5% VIAL 250ML medical products to support military healthcare programs. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the...
- The Defense Logistics Agency awarded a $1,650.75 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ALBUKED-5 VIAL 250ML, with an ultimate completion date of August 21, 2025. This non-set-aside contract was competitively awarded and represents a child order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters...
- The Defense Logistics Agency awarded a delivery order valued at $1,140.75 to AmerisourceBergen Drug Corp for the supply of ALBUKED-25 VIAL 100ML, with an ultimate completion date of August 21, 2025. This firm fixed-price delivery order represents a non-competitive, non-set-aside award to the pharmaceutical distributor's Corporate Office location in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ALBUTEIN 25% VIAL 100ML, a medical product, with a ceiling value of $1,107.12. The contract has an ultimate completion date of April 23, 2025. This appears to be a Delivery Order contract with a Firm Fixed Price pricing type. The contract is not designated with any set-aside requirements,...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $3,744.72 on August 21, 2025, for the supply of Albumin (Human) 25% intravenous solution in 50mL units. This is a firm fixed price, non-competitive delivery order with an ultimate completion date of September 12, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency...
- The Defense Logistics Agency awarded a $2,662.80 delivery order to AmerisourceBergen Drug Corp for ALBURX (Human) 5% Vial 500ML, a pharmaceutical product to be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This competitively awarded, firm fixed-price delivery order carries an ultimate completion date of August 14, 2025, and was issued on July 24, 2025. The award utilized no set-aside designation, reflecting AmerisourceBergen's qualification to compete in...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $6,231.00 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which has an ultimate completion date of January 26, 2024, is for the procurement of ALBUKED-5 VIAL 250ML medical products. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with DLA Troop Support Medical. The...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FP8S0Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,015.65 to AmerisourceBergen Drug Corp for Albutein 5% vials (250ml) under a firm fixed price contract type, with an ultimate completion date of September 4, 2025. This non-set-aside award was issued on August 13, 2025, with performance to be completed in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Conshohocken, serves as a critical vendor for federal medical procurement needs, particularly supporting military and veteran healthcare systems. This delivery order is a child contract issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This prime vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies globally to support military healthcare programs, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. The company's portfolio demonstrates its capability to meet federal procurement requirements through open competition, serving customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 8/13/25 |